Aardvark Therapeutics, Inc. Common Stock (AARD)
Healthcare
Biotechnology
6.60 $
+3.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Aardvark Therapeutics, Inc. Common Stock (AARD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 50.0% of the shares are freely tradable; institutional investors hold 56.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
56.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
16.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
50.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
22Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Decheng Capital LLC | 17.96 | 3,917,299 | +0.0 | 03/31/2026 |
| Citadel Advisors Llc | 5.70 | 1,242,777 | -3.6 | 03/31/2026 |
| LAURION CAPITAL MANAGEMENT LP | 4.74 | 1,034,459 | +1.9 | 03/31/2026 |
| BlackRock Inc | 3.63 | 792,571 | +1.0 | 03/31/2026 |
| Vanguard Group Inc | 3.29 | 717,430 | +29.1 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.54 | 554,101 | +0.0 | 03/31/2026 |
| Polygon Management Ltd | 1.45 | 316,621 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.42 | 309,449 | +3.9 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 1.38 | 300,000 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.87 | 408,670 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.